-
Delays in cancer screenings due to the coronavirus could lead to thousands of cancer deaths in the coming years. O’Neal Comprehensive Cancer Center at UAB is vigilant in its efforts to provide uninterrupted care to patients.
-
The O’Neal Comprehensive Cancer Center has been designated a Center of Excellence by the Myelodysplastic Syndromes Foundation, making it the only one in the state that holds this designation and can now provide patients access to an international network of[…]
-
In a talk at UAB on March 6, the NIH director shared his thoughts on exceptional opportunities for science and young scientists — and highlighted several exciting UAB projects.
-
In the first study of its kind, researchers identified genetic factors that can lead to a decrease in cognitive ability after a blood or bone marrow transplant.
-
Joining the Erdheim-Chester Disease Care Center Network has made UAB one of the 33 centers that can treat ECD.
-
UAB-led study finds that genetic variations associated with cognitive decline after BMT identify high-risk patients more accurately than current methods.
-
A harrowing diagnosis shook Luis Hurtado to his core, but the Blazer hoops player and Collat School of Business student beat the disease with the help of his UAB family.
-
An innovative study led by Luciano Costa, M.D., Ph.D., generated national buzz for its success in beating back blood cancer — and enrolling African American patients.
-
Single-cell sequencing enables researchers to study disease as never before — even skipping through time to follow crucial populations. UAB experts explain what all the fuss is about and how to get started in single-cell research — a field that is[…]
-
Noha Sharafeldin, MBBCh, Ph.D., of the Institute for Cancer Outcomes and Survivorship, used UAB’s supercomputer to identify biomarkers linked with cognitive impairment in patients who received a blood or marrow transplant. She’s also testing a way to repair the damage.